These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Potential use of RNA interference as therapeutic strategy in urologic cancer. Green WJ; James PA; Ratan HL Urology; 2011 Sep; 78(3):500-4. PubMed ID: 21741681 [No Abstract] [Full Text] [Related]
5. [Microsatellite instability in renal cell carcinoma and bladder tumors]. Matsuda H; Uejima S; Kurita T Hinyokika Kiyo; 1996 Jan; 42(1):27-31. PubMed ID: 8686579 [TBL] [Abstract][Full Text] [Related]
6. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray. Higgins JP; Kaygusuz G; Wang L; Montgomery K; Mason V; Zhu SX; Marinelli RJ; Presti JC; van de Rijn M; Brooks JD Am J Surg Pathol; 2007 May; 31(5):673-80. PubMed ID: 17460449 [TBL] [Abstract][Full Text] [Related]
8. Familial papillary renal cell tumors and subsequent cancers: a nationwide epidemiological study from Sweden. Czene K; Hemminki K J Urol; 2003 Apr; 169(4):1271-5. PubMed ID: 12629341 [TBL] [Abstract][Full Text] [Related]
9. Clinical implications of current developments in genitourinary pathology. Zhou AG; Owens CL; Cosar EF; Jiang Z Arch Pathol Lab Med; 2013 Jul; 137(7):887-93. PubMed ID: 23808460 [TBL] [Abstract][Full Text] [Related]
10. Novel blood biomarkers of human urinary bladder cancer. Osman I; Bajorin DF; Sun TT; Zhong H; Douglas D; Scattergood J; Zheng R; Han M; Marshall KW; Liew CC Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3374-80. PubMed ID: 16740760 [TBL] [Abstract][Full Text] [Related]
14. DNA methylation and expression of LINE-1 and HERV-K provirus sequences in urothelial and renal cell carcinomas. Florl AR; Löwer R; Schmitz-Dräger BJ; Schulz WA Br J Cancer; 1999 Jul; 80(9):1312-21. PubMed ID: 10424731 [TBL] [Abstract][Full Text] [Related]
15. Genitourinary malignancies. Smith MR; Kantoff P Cancer Chemother Biol Response Modif; 1999; 18():394-417. PubMed ID: 10800495 [No Abstract] [Full Text] [Related]
16. Genetics of urological cancers. Maher ER Br Med Bull; 1994 Jul; 50(3):698-707. PubMed ID: 7987649 [TBL] [Abstract][Full Text] [Related]
17. The germline mutational landscape of genitourinary cancers and its indication for prognosis and risk. Yang Y; Zhang G; Hu C; Luo W; Jiang H; Liu S; Yang H BMC Urol; 2022 Nov; 22(1):196. PubMed ID: 36451132 [TBL] [Abstract][Full Text] [Related]
18. Pharmacogenomics: New paradigms for targeted therapy based on individual response to drugs. Ganapathi RN; Ganapathi MK Urol Oncol; 2014 Jan; 32(1):1-4. PubMed ID: 24360658 [No Abstract] [Full Text] [Related]
19. Aberrant expression of growth factor Wnt-5A in six urinary malignant cell lines. Zhuang L; Zhang Z; Guo Y Chin Med J (Engl); 1999 Mar; 112(3):251-5. PubMed ID: 11593561 [TBL] [Abstract][Full Text] [Related]